ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
13.99
-0.47 (-3.25%)
At close: Aug 27, 2026, 4:00 PM EDT
14.27
+0.28 (2.00%)
After-hours: Aug 27, 2026, 7:54 PM EDT

ProMIS Neurosciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
------
Revenue Growth
------
Gross Profit
-35.66-33.38-10.64-7.88-16.09-4.63
Operating Income
-42.93-39.67-16.83-13.46-22.08-8.29
Net Income
-42.23-39.722.78-13.21-18.06-9.79
Earnings Per Share
-8.45-22.612.63-26.87-60.19-42.30
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
53.466.1513.3212.635.9216.98
Total Debt
-----3.91
Net Cash (Debt)
53.466.1513.3212.635.9213.08
Net Cash Growth
1076.78%-53.84%5.49%113.36%-54.73%1407.11%
Net Cash Per Share
10.703.5012.5925.6919.7356.51

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-42.11-28.12-27.18-10.84-17.03-9.31
Capital Expenditures
-----0-0.01
Free Cash Flow
-42.11-28.12-27.18-10.84-17.04-9.31
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--11.15---
PS Ratio
------